Shell Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Sell |
|
|||||
|
2025
Q1 | $49K | Sell |
|
|||||
|
2024
Q4 | $38K | Hold |
|
|||||
|
2024
Q3 | $31K | Buy |
|
|||||
|
2024
Q1 | $53K | Sell |
|
|||||
|
2023
Q4 | $71K | Sell |
|
|||||
|
2023
Q3 | $84K | Sell |
|
|||||
|
2023
Q2 | $111K | Sell |
|
|||||
|
2023
Q1 | $114K | Sell |
|
|||||
|
2022
Q4 | $108K | Sell |
|
|||||
|
2022
Q3 | $181K | Sell |
|
|||||
|
2022
Q2 | $250K | Buy |
|
|||||
|
2022
Q1 | $252K | Sell |
|
|||||
|
2021
Q4 | $228K | Buy |
|
|||||
|
2021
Q3 | $211K | Sell |
|
|||||
|
2021
Q2 | $239K | Buy |
|
|||||
|
2021
Q1 | $99K | Buy |
|